A new method of reversing Alzheimer's shows promise in an animal study, as researchers at University Hospitals restore brain ...

While the country faces an ongoing physician shortage, the nationwide neurologist shortage is even greater. Given the needs ...

Dogs are sticking around longer these days, and with those extra years come new challenges, especially ones that many owners ...

About one in nine adults suffer from chronic insomnia and its residual effects like drowsiness, cognitive issues, and ...

Sleep hygiene refers to habits that support good-quality sleep. These include allowing enough time for sleep, keeping your ...

FDA grants Priority Review to AXS-05 (dextromethorphan/bupropion) for the treatment of agitation associated with Alzheimer disease.

The biopharmaceutical company accepted for filing a supplemental new drug application for AXS-05 to treat Alzheimer's disease agitation, and has granted the application priority review designation, ...

At the end of the study, the results showed that people with chronic insomnia had a 40 percent higher risk of developing mild ...

About one in nine adults suffer from chronic insomnia and its residual effects like drowsiness, cognitive issues, and ...

FDA grants AXS-05 Priority Review designation and sets PDUFA action goal date of April 30, 2026NEW YORK, (GLOBE NEWSWIRE) -- ...

Blood-based biomarkers, such as Roche’s pTau181 test, offer a powerful tool for identifying the right patients for Alzheimer’s disease clinical trials early. This October saw a landmark development in ...

New safety study links sedative use to increased stroke risk. A large UK study involving more than 165,000 people with dementia has found that the drug risperidone increases the risk of stroke in all ...